ponatinib,blinatumomab
takeda,incyte,otsuka,amgen
['leusm', 'ponatinib', 'blina ']
congress #eha2023 | discusses subanalysis of a phase ii study of ponatinib +blina for ndph+all. 37/38 achieved cr or cri &amp; 36 achieved cr. among the 54 pts evaluable for cmr, 67% achieved cmr after c1, &amp; 83% achieved cmr at any time. #leusm #allsm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm